Here, we found that translation initiation factor eIF4E1, but not eIF4E2, eIF4G1, eIF1A, eIF2α, or eIF5, is significantly enhanced in breast CSCs in comparison to non-CSC breast cancer cells. The gene discussed is EIF5; the disease is breast carcinoma.